VIBGLIB M 5/500 GLIBENCLAMIDE 5mg. IP + METFORMIN 500mg. IP

Vibglib M 5/500 tablets combine glibenclamide 5 mg and metformin 500 mg to improve blood sugar control in type 2 diabetes. Main uses: used as an addition to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.; brings down both fasting and after-meal blood glucose levels.; works on blood sugar through two different actions in the body..

Common side effects of Vibglib M 5/500 Tablet include loose motions (diarrhoea); headache; nausea and vomiting; stomach or abdominal pain; dizziness; low blood sugar (sweating, shakiness, hunger, palpitations). Get medical help at once if you notice lactic acidosis (rare): unusual muscle pain, breathing difficulty, feeling drowsy, stomach pain with vomiting - needs urgent medical help; severe low blood sugar; possible increased risk of cardiovascular mortality with sulfonylureas; discuss risks, benefits and treatment alternatives with a doctor.

Each Vibglib M 5/500 tablet contains Glibenclamide 5 mg + Metformin 500 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Vibglib M 5/500 Tablet only as your doctor advises.

The MRP of Vibglib M 5/500 Tablet is ₹54 for a pack of 10x10 (Blister). For chemists and distributors, the PTR is ₹41.14 and the PTS is ₹37.03.

Each Vibglib M 5/500 tablet contains Glibenclamide 5 mg + Metformin 500 mg. It comes in a pack of 10x10 (Blister).

Glibenclamide works on the pancreas and encourages the release of insulin from its beta cells, which helps clear glucose from the blood. Metformin acts in a different way: it lowers the amount of glucose produced by the liver, reduces glucose absorbed from food in the intestine and improves the body's response to insulin so that more glucose is taken up and used. The two ingredients together address blood sugar from more than one direction.

Must not be used in patients with severe kidney impairment. Must not be used if the patient is allergic to glibenclamide or metformin. Must not be used in diabetic ketoacidosis or any other metabolic acidosis, with or without coma. Must not be used with bosentan. Check with a doctor first in elderly patients, in patients with kidney problems, in G6PD deficiency, and if any other anti-diabetic medicine is being taken.

Vibglib M 5/500 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.